Evidence map›Paper›PMID 38419681›Full record

ReviewRSC advances2024

Carbon-based nanocomposites for biomedical applications.

Minkyu Shin, Joungpyo Lim, Yongseon Park, Ji-Young Lee, Jinho Yoon, Jeong-Woo Choi

Abstract readReview
In one paragraph

Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Nanoparticle-Based Drug Delivery for Vascular Applications.Bioengineering (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Minkyu ShinDepartment of Chemical & Biomolecular Engineering, Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 04107 Republic of Korea jwchoi@sogang.ac.kr.
Joungpyo LimDepartment of Chemical & Biomolecular Engineering, Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 04107 Republic of Korea jwchoi@sogang.ac.kr.
Yongseon ParkDepartment of Chemical & Biomolecular Engineering, Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 04107 Republic of Korea jwchoi@sogang.ac.kr.
Ji-Young LeeDepartment of Chemical & Biomolecular Engineering, Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 04107 Republic of Korea jwchoi@sogang.ac.kr.
Jinho YoonDepartment of Biomedical-Chemical Engineering, The Catholic University of Korea 43 Jibong-ro, Wonmi-gu Bucheon-si Gyeonggi-do 14662 Republic of Korea jyoon@catholic.ac.kr.
Jeong-Woo ChoiDepartment of Chemical & Biomolecular Engineering, Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 04107 Republic of Korea jwchoi@sogang.ac.kr.ORCID https://orcid.org/0000-0003-0100-0582

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon nanomaterials have attracted significant attention in the biomedical field, including for biosensing, drug delivery, and tissue engineering applications. Based on their inherent properties such as their unique structure and high conductivity, carbon nanomaterials can overcome the current limitations in biomedical research such as poor stability of biomolecules, low sensitivity and selectivity of biosensors, and difficulty in precise drug delivery. In addition, recently, several novel nanomaterials have been integrated with carbon nanomaterials to develop carbon-based nanocomposites for application in biomedical research. In this review, we discuss recent studies on carbon-based nanocomposites and their biomedical applications. First, we discuss the representative carbon nanomaterials and nanocomposites composed of carbon and other novel nanomaterials. Next, applications of carbon nanomaterials and nanocomposites in the biomedical field are discussed according to topics in the biomedical field. We have discussed the recent studies on biosensors, drug delivery, and tissue engineering. In conclusion, we believe that this review provides the potential and applicability of carbon nanomaterials and their nanocomposites and suggests future directions of the application of carbon-based nanocomposites in biomedical applications.

Identifiers

PMID38419681
PMCPMC10900039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.